On Feb. 17, the U.S. Food and Drug Administration (FDA) announced the approval of Korlym (mifepristone) to control hyperglycemia in adults with endogenous Cushing’s syndrome who have type 2 diabetes or glucose intolerance and are not candidates for surgery or who have not responded to prior surgery. Read more.

FDA approves Korlym for hyperglycemia in patients with endogenous Cushing’s syndrome

FDA warns of counterfeit Avastin

Public reporting of quality data has not significantly reduced mortality

C. difficile infections at record high

Joint Commission awards first certifications for palliative care

Visits to ED for dental problems increase

Polypectomy lowers colorectal cancer mortality

Use of bone morhphogenetic proteins not associated less reoperation for lumbar stenosis

AHRQ reports results from survey on patient safety culture

Nurses, physicians differ in perceptions of physician abuse or disrespect

Study finds patient satisfaction is associated with higher mortality

From our readers…Know your A, B, C, and D’s for patients with progressive disease

From our readers…Beauty in the eye of the beholder: The life of a wound, ostomy, and continence nurse

Creating a smooth move for patients and staff

From our readers…Practical approaches to patient advocacy barriers

Genetic counseling, abortion, sex-selection, and autonomy

Putting evidence into practice: Chemotherapy-induced peripheral neuropathy

Physiology review: Circulatory system

Preventing urinary tract infections in patients with indwelling catheters

Reducing barriers to practice for Missouri APRNs

ICIRN releases new edition of Essential Nursing Resources

Air Force recognizes CRNAs’ full scope of practice

ANA releases 2011 Health and Safety Survey results

Save a life—yours (and your patients’)!

Viewpoint: Why nurses will require a stronger back in 2012: Six key challenges facing the nursing community

Are you ready to care for patients in clinical trials?

Okay to play? A discussion about sports-related concussion

Americannursetoday x Dress-Lace.com Lace Maxi Dress

January 2012 e-Edition

Making the transformation to a customer-service orientation

Does evidence-based nursing increase ROI?

FDA warns of drug interactions between Victrelis and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors

FDA announces agreement in principle on medical device user fees

U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

FDA announces guidelines for polymyxin, vecuronium recall

HHS panel recommends mandatory flu vaccination for health care workers